Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Mao Mizuta
Observed names:
M Mizuta,
MAO MIZUTA,
MIZUTA, Mao,
Mizuta, Mao
Institution:
Kobe Children's Hospital
Observed institutions:
Kanazawa University,
Universidad El Bosque,
Alder Hey Children's NHS Foundation Trust,
Kobe Children's Hospital,
Centre Hospitalier Universitaire Ibn Rochd,
Archbishop Makarios III Hospital,
Alder Hey Children's Hospital
show all 7
ORCID:
0009-0006-3957-5428
Observed ORCID:
0009-0006-3957-5428
OpenAlex ID:
A5036860714
Interleukin-18 for predicting the development of macrophage activation syndrome in systemic juvenile idiopathic arthritis
2015
·
Masaki Shimizu
, Yasuo Nakagishi
, et al.
·
Clinical Immunology
·
180
Clinical significance of serum CXCL9 levels as a biomarker for systemic juvenile idiopathic arthritis associated macrophage activation syndrome
2019
·
Mao Mizuta
, Masaki Shimizu
, et al.
·
Cytokine
·
56
Current treatment in macrophage activation syndrome worldwide: a systematic literature review to inform the METAPHOR project
2024
·
Francesco Baldo
, Remco G A Erkens
, et al.
·
Rheumatology
·
53
Tocilizumab modifies clinical and laboratory features of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis
2020
·
Masaki Shimizu
, Mao Mizuta
, et al.
·
Pediatric Rheumatology
·
50
PDF
Cytokine profile of macrophage activation syndrome associated with Kawasaki disease
2019
·
Asumi Jinkawa
, Masaki Shimizu
, et al.
·
Cytokine
·
47
Characteristic elevation of soluble TNF receptor II : I ratio in macrophage activation syndrome with systemic juvenile idiopathic arthritis
2017
·
M Shimizu
, N Inoue
, et al.
·
Clinical & Experimental Immunology
·
47
Serum ferritin levels as a useful diagnostic marker for the distinction of systemic juvenile idiopathic arthritis and Kawasaki disease
2016
·
Mao Mizuta
, Masaki Shimizu
, et al.
·
Modern Rheumatology
·
45
Soluble CD163, a unique biomarker to evaluate the disease activity, exhibits macrophage activation in systemic juvenile idiopathic arthritis
2018
·
Naoto Sakumura
, Masaki Shimizu
, et al.
·
Cytokine
·
44
Clinical features and characteristics of uveitis associated with juvenile idiopathic arthritis in Japan: first report of the pediatric rheumatology association of Japan (PRAJ)
2019
·
Junko Yasumura
, Masato Yashiro
, et al.
·
Pediatric Rheumatology
·
41
PDF
Clinical significance of interleukin-18 for the diagnosis and prediction of disease course in systemic juvenile idiopathic arthritis
2020
·
Mao Mizuta
, Masaki Shimizu
, et al.
·
Rheumatology
·
40
Comparison of serum cytokine profiles in macrophage activation syndrome complicating different background rheumatic diseases in children
2020
·
Mao Mizuta
, Masaki Shimizu
, et al.
·
Rheumatology
·
40
Comparison of serum biomarkers for the diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis
2019
·
Maiko Takakura
, Masaki Shimizu
, et al.
·
Clinical Immunology
·
30
Extensive serum biomarker analysis in patients with macrophage activation syndrome associated with systemic lupus erythematosus
2019
·
Masaaki Usami
, Masaki Shimizu
, et al.
·
Clinical Immunology
·
23
Serum Leucine-Richα2-Glycoprotein as a Biomarker for Monitoring Disease Activity in Patients with Systemic Juvenile Idiopathic Arthritis
2019
·
Masaki Shimizu
, Natsumi Inoue
, et al.
·
Journal of Immunology Research
·
22
PDF
Validation of Classification Criteria of Macrophage Activation Syndrome in Japanese Patients With Systemic Juvenile Idiopathic Arthritis
2017
·
Masaki Shimizu
, Mao Mizuta
, et al.
·
Arthritis Care & Research
·
22
Proceedings of the 23rd Paediatric Rheumatology European Society Congress: part one
2017
·
F. De Benedetti
, PRINTO/PRCSG
, et al.
·
Pediatric Rheumatology
·
21
PDF
Leopard skin appearance of cutaneous polyarteritis nodosa on18Ffluorodeoxyglucose positron emission tomography
2016
·
Masaki Shimizu
, Natsumi Inoue
, et al.
·
Rheumatology
·
21
Clinical significance of serum cytokine profiles for differentiating between Kawasaki disease and its mimickers
2023
·
Shuya Kaneko
, Masaki Shimizu
, et al.
·
Cytokine
·
18
Leucine-rich α2-glycoprotein as the acute-phase reactant to detect systemic juvenile idiopathic arthritis disease activity during anti-interleukin-6 blockade therapy: A case series
2017
·
Masaki Shimizu
, Yasuo Nakagishi
, et al.
·
Modern Rheumatology
·
17
Transient natural killer cell dysfunction associated with interleukin‐18 overproduction in systemic juvenile idiopathic arthritis
2018
·
Maiko Takakura
, Masaki Shimizu
, et al.
·
Pediatrics International
·
16
Serum Cytokine Profiling Differentiates Underlying Diseases in Cytokine Storm Syndrome
2025
·
Shuya Kaneko
, Maho Hatano
, et al.
·
Arthritis & Rheumatology
·
15
Apoptosis inhibitor of macrophage as a biomarker for disease activity in Japanese children with IgA nephropathy and Henoch–Schönlein purpura nephritis
2020
·
Hitoshi Irabu
, Masaki Shimizu
, et al.
·
Pediatric Research
·
15
Epidemiology conduction of paediatric rheumatic diseases based on the registry database of the Pediatric Rheumatology Association of Japan
2022
·
Hidehiko Narazaki
, Shinji Akioka
, et al.
·
Modern Rheumatology
·
14
Clinical significance of serum soluble TNF receptor II level and soluble TNF receptor II/I ratio as indicators of coronary artery lesion development in Kawasaki disease
2018
·
Masaki Shimizu
, Mao Mizuta
, et al.
·
Cytokine
·
14
Comparison of serum biomarkers for the diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis during tocilizumab therapy
2020
·
Hitoshi Irabu
, Masaki Shimizu
, et al.
·
Pediatric Research
·
13
Show more works
View as search
Works count:
78
Citation count:
1,148
H-index:
20
I10-index:
31
Year
Topic
Type
